Literature DB >> 6119549

Valproate in Cushing's syndrome.

B Allolio, W Winkelmann, D Kaulen, F X Hipp, R Mies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6119549     DOI： 10.1016/s0140-6736(82)90422-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

2.  Failure of long-term therapy with sodium valproate in Cushing's disease.

Authors:  A Colao; R Pivonello; F S Tripodi; F Orio; D Ferone; G Cerbone; C Di Somma; B Merola; G Lombardi
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

3.  Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.

Authors:  B Ambrosi; D Bochicchio; E Riva; G Faglia
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

4.  The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.

Authors:  M Reincke; B Allolio; D Kaulen; C Jaursch-Hancke; W Winkelmann
Journal:  Klin Wochenschr       Date:  1988-08-01

5.  Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.

Authors:  P Loli; M E Berselli; F Frascatani; F Muratori; M Tagliaferri
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.